Hydroxocobalamin Orion

Hydroxocobalamin, the active ingredient in Hydroxocobalamin Orion, is a vitamin B12 (cobalamin) presented as an injectable solution for intramuscular use. It treats cyanide poisoning and vitamin B12 deficiency in patients who need rapid restoration of cobalamin activity.

GNH USA supplies Hydroxocobalamin Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies, clinics and other healthcare facilities worldwide.

Hydroxocobalamin Orion is used to address conditions related to cyanide toxicity and vitamin B12 deficiency. Cyanide poisoning: neutralizes cyanide by forming cyanocobalamin, facilitating detoxification. Vitamin B12 deficiency: restores normal cobalamin levels, supporting red blood cell formation and neurological function. Megaloblastic anemia: corrects macrocytic anemia caused by insufficient vitamin B12.

Adverse reactions to Hydroxocobalamin Orion may vary in frequency and severity.

Common Side Effects: - Injection site pain: mild discomfort at the intramuscular injection site. - Redness or swelling: localized erythema or edema. - Headache: transient headache following administration. - Nausea: mild nausea reported by some patients. - Dizziness: occasional light‑headedness after injection.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Hypotension: sudden drop in blood pressure post‑dose. - Hypertension: elevated blood pressure in susceptible individuals. - Arrhythmia: cardiac rhythm disturbances observed rarely. - Severe injection site necrosis: extensive tissue damage at the injection site.

Before prescribing Hydroxocobalamin Orion, clinicians should consider several safety measures. Assess B12 status: confirm deficiency or cyanide exposure before administration. Monitor for hypersensitivity: observe patients for signs of allergic reaction during and after injection. Use with caution in renal impairment: adjust monitoring as reduced clearance may affect plasma levels. Avoid in known cobalamin hypersensitivity: contraindicated in patients with documented allergy to hydroxocobalamin or related compounds. Pregnancy and lactation: safety category unknown; weigh potential benefits against risks before use. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Hydroxocobalamin may interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Metformin: may mask B12 deficiency, reducing clinical benefit. - Proton pump inhibitors: decrease gastric acidity, potentially lowering oral B12 absorption (less relevant for injectable but caution advised). - Chloramphenicol: may interfere with cobalamin metabolism.

Moderate Interactions (Monitor Closely): - Phenytoin: anticonvulsant that can reduce B12 levels, requiring monitoring. - Trimethoprim: may impair folate metabolism, enhancing hematologic effects. - Oral contraceptives: possible alteration of B12 binding proteins, monitor serum levels.